Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients
Clinical trial NCT04843579 · TERMINATED
Trial details
- NCT number
- NCT04843579
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-29
- Primary completion
- 2022-11-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.